Use of immunosuppressive agents in the treatment of severe ocular and vascular manifestations of Cogan's syndrome.
Allen
N B
NB
Division of Rheumatology and Immunology, Duke University Medical Center, Durham, North Carolina.
Cox
C C
CC
Cobo
M
M
Kisslo
J
J
Jacobs
M R
MR
McCallum
R M
RM
Haynes
B F
BF
D000293:Adolescent; D000328:Adult; D002318:Cardiovascular Diseases / Q000150:complications / Q000175:diagnosis; D005260:Female; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use*; D007634:Keratitis / Q000150:complications / Q000188:drug therapy*; D007759:Labyrinth Diseases / Q000150:complications / Q000188:drug therapy*; D008297:Male; D013577:Syndrome; D014657:Vasculitis / Q000150:complications / Q000188:drug therapy* / Q000473:pathology
D007166:Immunosuppressive Agents